BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 34628056)

  • 1. Pathogenicity of VHL variants in families with non-syndromic von Hippel-Lindau phenotypes: An integrated evaluation of germline and somatic genomic results.
    Rana HQ; Koeller DR; Schwartz A; Manning DK; Schneider KA; Krajewski KM; Choueiri TK; Lindeman NI; Garber JE; Ghazani AA
    Eur J Med Genet; 2021 Dec; 64(12):104359. PubMed ID: 34628056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of genomic alterations in non-syndromic von Hippel-Lindau: Insight from integrating somatic and germline next generation sequencing genomic data.
    Manning DK; Shivdasani P; Koeller DR; Schwartz A; Rana HQ; Garber JE; Lindeman NI; Ghazani AA
    Data Brief; 2021 Dec; 39():107653. PubMed ID: 34934780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo VHL germline mutation detected in a patient with mild clinical phenotype of von Hippel-Lindau disease.
    Ding X; Zhang C; Frerich JM; Germanwala A; Yang C; Lonser RR; Mao Y; Zhuang Z; Zhang M
    J Neurosurg; 2014 Aug; 121(2):384-386. PubMed ID: 24678776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline mutations in the new E1' cryptic exon of the
    Buffet A; Calsina B; Flores S; Giraud S; Lenglet M; Romanet P; Deflorenne E; Aller J; Bourdeau I; Bressac-de Paillerets B; Calatayud M; Dehais C; De Mones Del Pujol E; Elenkova A; Herman P; Kamenický P; Lejeune S; Sadoul JL; Barlier A; Richard S; Favier J; Burnichon N; Gardie B; Dahia PL; Robledo M; Gimenez-Roqueplo AP
    J Med Genet; 2020 Nov; 57(11):752-759. PubMed ID: 31996412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Von Hippel-Lindau disease germline mutations in Mexican patients with cerebellar hemangioblastoma.
    Rasmussen A; Nava-Salazar S; Yescas P; Alonso E; Revuelta R; Ortiz I; Canizales-Quinteros S; Tusié-Luna MT; López-López M
    J Neurosurg; 2006 Mar; 104(3):389-94. PubMed ID: 16572651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenicity of DNA variants and double mutations in multiple endocrine neoplasia type 2 and von Hippel-Lindau syndrome.
    Erlic Z; Hoffmann MM; Sullivan M; Franke G; Peczkowska M; Harsch I; Schott M; Gabbert HE; Valimäki M; Preuss SF; Hasse-Lazar K; Waligorski D; Robledo M; Januszewicz A; Eng C; Neumann HP
    J Clin Endocrinol Metab; 2010 Jan; 95(1):308-13. PubMed ID: 19906784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system.
    Gläsker S; Bender BU; Apel TW; Natt E; van Velthoven V; Scheremet R; Zentner J; Neumann HP
    J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):758-62. PubMed ID: 10567493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and molecular characterization of Brazilian families with von Hippel-Lindau disease: a need for delineating genotype-phenotype correlation.
    Gomy I; Molfetta GA; de Andrade Barreto E; Ferreira CA; Zanette DL; Casali-da-Rocha JC; Silva WA
    Fam Cancer; 2010 Dec; 9(4):635-42. PubMed ID: 20567917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of a germline mutation and somatic homozygous loss of the von Hippel-Lindau tumor-suppressor gene in a family with a de novo mutation. A combined genetic study, including cytogenetics, PCR/SSCP, FISH, and CGH.
    Decker HJ; Neuhaus C; Jauch A; Speicher M; Ried T; Bujard M; Brauch H; Störkel S; Stöckle M; Seliger B; Huber C
    Hum Genet; 1996 Jun; 97(6):770-6. PubMed ID: 8641695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline mutation profile of the VHL gene in von Hippel-Lindau disease and in sporadic hemangioblastoma.
    Olschwang S; Richard S; Boisson C; Giraud S; Laurent-Puig P; Resche F; Thomas G
    Hum Mutat; 1998; 12(6):424-30. PubMed ID: 9829912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of Von Hippel-Lindau germline mutations in classic and non-classic Von Hippel-Lindau disease identified by DNA sequencing, Southern blot analysis and multiplex ligation-dependent probe amplification.
    Hes FJ; van der Luijt RB; Janssen AL; Zewald RA; de Jong GJ; Lenders JW; Links TP; Luyten GP; Sijmons RH; Eussen HJ; Halley DJ; Lips CJ; Pearson PL; van den Ouweland AM; Majoor-Krakauer DF
    Clin Genet; 2007 Aug; 72(2):122-9. PubMed ID: 17661816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptic von Hippel-Lindau disease: germline mutations in patients with haemangioblastoma only.
    Hes FJ; McKee S; Taphoorn MJ; Rehal P; van Der Luijt RB; McMahon R; van Der Smagt JJ; Dow D; Zewald RA; Whittaker J; Lips CJ; MacDonald F; Pearson PL; Maher ER
    J Med Genet; 2000 Dec; 37(12):939-43. PubMed ID: 11106358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecularly genetic analysis of von Hippel-Lindau associated central nervous system hemangioblastoma.
    Zhou J; Wang J; Li N; Zhang X; Zhou H; Zhang R; Ma H; Zhou X
    Pathol Int; 2010 Jun; 60(6):452-8. PubMed ID: 20518900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline mutations in the von Hippel-Lindau disease (VHL) gene in mainland Chinese families.
    Zhang J; Huang Y; Pan J; Liu D; Zhou L; Xue W; Chen Q; Dong B; Xuan H
    J Cancer Res Clin Oncol; 2008 Nov; 134(11):1211-8. PubMed ID: 18446368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Large germline deletion of the VHL gene in Chinese families with von Hippel-Lindau syndrome].
    Zhang J; Chen HG; Xue W; Zhou LX; Huang YR
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Oct; 26(5):539-41. PubMed ID: 19806577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An optimized protocol for evaluating pathogenicity of
    Koeller DR; Manning DK; Schwartz A; Chittenden A; Hayes CP; Abraamyan F; Rana HQ; Lindeman NI; Garber JE; Ghazani AA
    MethodsX; 2022; 9():101761. PubMed ID: 35774415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic study of a large Chinese kindred with von Hippel-Lindau disease.
    Huang YR; Zhang J; Wang JD; Fan XD
    Chin Med J (Engl); 2004 Apr; 117(4):552-7. PubMed ID: 15109448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline VHL gene mutations in three Serbian families with von Hippel-Lindau disease.
    Stanojevic BR; Lohse P; Neskovic GG; Damjanovic SM; Novkovic TB; Jovanovic-Cupic SP; Dimitrijević BB
    Neoplasma; 2007; 54(5):402-6. PubMed ID: 17688370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-exome sequencing and immunohistochemistry findings in von Hippel-Lindau disease.
    Guo X; Gao L; Hong X; Guo D; Di W; Wang X; Xu Z; Xing B
    Mol Genet Genomic Med; 2019 Sep; 7(9):e880. PubMed ID: 31317677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma.
    Whaley JM; Naglich J; Gelbert L; Hsia YE; Lamiell JM; Green JS; Collins D; Neumann HP; Laidlaw J; Li FP
    Am J Hum Genet; 1994 Dec; 55(6):1092-102. PubMed ID: 7977367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.